What company manufactures Plavix?

What company manufactures Plavix?

Bristol-Myers Squibb – Sanofi Pharmaceuticals
Plavix is made under a Bristol-Myers Squibb – Sanofi Pharmaceuticals partnership.

Where is Plavix manufactured?

S made at a factory in India, due to quality concerns about the heart drug. Plavix, or clopidogrel, is sold as a brand by Sanofi-Aventis SASY.PA and Bristol-Myers Squibb BMY. N. It is the world’s second biggest selling medicine, with worldwide sales of more than $9 billion a year.

What is the generic brand for Plavix?

Clopidogrel, the generic Plavix, is used to treat patients who have had a recent heart attack, but that’s not all. Here are a few ways clopidogrel helps us out: – It is used to stop heart attacks. – It is used to stop strokes.

How much does cangrelor cost?

The standard dosage to treat one patient undergoing percutaneous coronary intervention (PCI) with cangrelor (Kengreal) will have a wholesale acquisition cost of $749, Raymond Russo, senior vice president of The Medicines Company, said at a June 23 press briefing.

Who manufactures Bristol Myers Squibb?

Bristol Myers Squibb

A Bristol Myers Squibb R&D facility in Lawrence, New Jersey
Industry Pharmaceuticals
Founded 1887
Founders William McLaren Bristol John Ripley Myers E. R. Squibb
Headquarters 430 East 29th Street New York City, New York, United States

Is there a class action lawsuit against Plavix?

Plaintiffs say the blood-thinning product made by Bristol-Myers Squibb has caused excessive bleeding, brain injuries, and even death. Legal action is apparently moving forward involving lawsuits filed by thousands of people who say they suffered serious injuries by taking the once-heralded blood-thinning drug Plavix.

What is the brand name for memantine?

Memantine oral tablet is available as a brand-name drug and a generic drug. Brand name: Namenda. Memantine comes in three forms: immediate-release tablet, oral solution, and extended-release capsule. Memantine oral tablet is used to treat moderate to severe dementia caused by Alzheimer’s disease.

Is cangrelor FDA approved?

BETHESDA, MD — Cangrelor (Kengreal, the Medicines Company), an intravenous antiplatelet agent, is now approved by the US Food and Drug Administration (FDA) for reducing thrombotic events in patients undergoing PCI.

Can Plavix be given IV?

Conclusions: MDCO-157, an intravenous formulation of clopidogrel complexed with sulphobutylether betacyclodextrin, did not show significant platelet inhibition when administered at doses up to 300 mg. Higher doses with longer infusion may be needed to reach a sufficient threshold of active metabolite generation.